Drugs / FLOTUFOLASTAT
FLOTUFOLASTAT
also known as
flotufolastat F 18 · fluorine F 18 flotufolastat · 18F-rhPSMA-7.3 · flotufolastat (18F) · rhPSMA-7.3C
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT07149831 | Jun → Dec 2025 overdue | prostate cancer | Sinotau Pharmaceutical Group | Recruiting | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT07220720 | Nov 2025 → Jul 2030 expected | prostate cancer | University of Florida | Recruiting | No outcome recorded |
| Phase 2 | NCT07185165 | Oct 2025 → Oct 2035 expected | prostate carcinoma | Jonsson Comprehensive Cancer Center | Recruiting | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT06604442 | Dec 2024 → Aug 2025 | prostate cancer | Blue Earth Diagnostics | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06881823 Comparator | Jun 2026 → Mar 2030 | prostate cancer | Novartis Pharmaceuticals | Withdrawn | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FLOTUFOLASTAT | ChEMBL registry synonym — accepted as the source's own label CHEMBL5316155 ↗ |
| Known as | 18F-rhPSMA-7.3 | “PSMA-PET radiopharmaceuticals, 18F-piflufolastat (18F-DCFPyL) and 18F-flotufolastat (18F-rhPSMA-7.3) in patients with biochemical recurrence (BCR) of prostate cancer” PMID 41729277 ↗ Feb 2026 |
| Known as | flotufolastat (18F) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06604442 ↗ |
| Known as | flotufolastat F 18 | “Flotufolastat F 18 is a radioactive tracer that binds to prostate specific membrane antigen (PSMA), a protein over-expressed on prostate tumor cells.” NCT07185165 ↗ |
| Known as | fluorine F 18 flotufolastat | “To evaluate the accuracy of fluorine F 18 flotufolastat (flotufolastat F 18) compared with prostate biopsy to determine treatment success following focal therapy of the prostate.” NCT07185165 ↗ |
| Known as | rhPSMA-7.3C | ChEMBL registry synonym — accepted as the source's own label CHEMBL5316155 ↗ |
| Modality | Diagnostic / imaging agent | “positron emission tomography (PET) imaging tracer” NCT07149831 ↗ |
| Route | Intravenous | “Subjects will receive 5.47\~6.69mCi of Flotufolastat F-18 Injection via IV injection.” NCT07149831 ↗ |